Esa Medika Mandiri Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Esa Medika Mandiri Tbk. trades at Rp358 (market cap 620.46B, 8.41M 24h volume), while Chandra Asri Pacific Tbk. trades at Rp2,060 (market cap 186.86T, 330.51M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 301.2× Esa Medika Mandiri Tbk.'s market cap, and Chandra Asri Pacific Tbk. is more actively traded (330.51M versus 8.41M). Which is the better fit depends on your goals.
| EMMI | TPIA | |
|---|---|---|
Market Cap | 620.46B | 186.86T |
Volume | 8.41M | 330.51M |
Lot | 84.09K | 3.31M |
Turnover | 2.92B | 687.87B |
Average Price | 347.69 | 2,081.25 |
Value | 2.92B | 687.87B |
Indicative Equilibrium Price | 358 | 2,060 |
Indicative Equilibrium Volume | 3.01K | 66.16K |
Trailing returns across standard periods
Latest headlines on both assets
PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.
Read more on EMMI →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →